Tag Archive for: Iovance

Posts

Iovance Biotherapeutics Announces New Facility at the Navy Yard to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for commercial and clinical production of autologous TIL products, including its candidate lifileucel. Read more

Navy Yard

The Navy Yard is considered the most successful redevelopment of a former military facility in the country and today is a growing community where companies and their employees thrive. Future growth will support up to 10 million square feet of commercial and residential development.

COPYRIGHT © PIDC ALL RIGHTS RESERVED – DESIGNED BY LEVLANE